Development and initial testing of the stroke rapid-treatment readiness tool.


No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.





Published Version (Please cite this version)


Publication Info

Olson, DaiWai M, Margueritte Cox, Mark Constable, Gavin W Britz, Cheryl B Lin, Louise O Zimmer, Gregg C Fonarow, Lee H Schwamm, et al. (2014). Development and initial testing of the stroke rapid-treatment readiness tool. J Neurosci Nurs, 46(5). pp. 267–273. 10.1097/JNN.0000000000000082 Retrieved from

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.